Finance

Beta
Lists
MMED:NASDAQ
MiniMed Group Inc
$14.13
+2.84%
(+0.39) 1D
$14.10
-0.21% (-0.030)
After hours
Closed: Jun 24, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MMED...
Open
$13.97
High
$14.98
Low
$13.95
Mkt. cap
3.97B
Avg. vol.
905.25K
Volume
7.00
52-wk high
$20.48
52-wk low
$10.65
EPS
-$1.29
No. of employees
8K
Open
$13.97
High
$14.98
Low
$13.95
Mkt. cap
3.97B
Avg. vol.
905.25K
Volume
7.00
52-wk high
$20.48
52-wk low
$10.65
EPS
-$1.29
No. of employees
8K
News stories
From sources across the web
About MiniMed Group Inc
CEO-
Employees8K
Founded1983
Headquarters-
SectorMedical device
Websiteminimed.com
Analyst Ratings
Based on 13 analysts giving stock ratings to MMED in the past 3 months
Strong Buy
Buy
12
Hold
1
Sell
0
12 month forecast
Based on 13 Wall Street analysts offering 12 month price targets for MMED in the last 3 months.
Highest
Current $14.13
$26.00 (+84.01%)
Average
$21.67 (+53.36%)
Lowest
$16.00 (+13.23%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Steven Lichtman
William Blair
Buy
Maintained
-
-
06/17/2026
Marie Thibault
BTIG
Buy
Maintained
$25.00
+76.9%
06/15/2026
Larry Biegelsen
Wells Fargo
Buy
Maintained
$26.00
+84%
06/08/2026
Travis Steed
Bank of America Securities
Buy
Maintained
$20.00
+41.5%
06/08/2026
Daniel Markowitz CFA
Evercore ISI
Buy
Maintained
$20.00
+41.5%
06/05/2026
Anthony Petrone
Mizuho Securities
Buy
Maintained
$21.00
+48.6%
06/03/2026
Matthew O'Brien
Piper Sandler
Hold
Reiterated
$16.00
+13.2%
06/04/2026
David Roman
Goldman Sachs
Buy
Maintained
$24.00
+69.9%
06/03/2026
Bruce Jackson
Benchmark Co.
Buy
Maintained
$20.00
+41.5%
06/03/2026
Kallum Titchmarsh
Morgan Stanley
Buy
Maintained
$19.00
+34.5%
06/05/2026
Joanne Wuensch
Citi
Buy
Maintained
$23.00
+62.8%
06/03/2026
Pito Chickering
Deutsche Bank
Buy
Initiated
$20.00
+41.5%
03/31/2026
Matt Miksic
Barclays
Buy
Initiated
$26.00
+84%
03/31/2026
Unknown Analyst
Morgan Stanley
Buy
Initiated
$19.00
+34.5%
03/31/2026
Last report
Jun 3, 2026
Fiscal period
Q4 2026
EPS / Est. (USD)
-$0.68 / -$0.22
-204.48%miss
Revenue / Est. (USD)
837.00M / 826.52M
+1.27%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Revenue
737.50M
737.50M
790.00M
837.00M
Cost of goods sold
318.50M
318.50M
422.00M
357.00M
Cost of revenue
318.50M
318.50M
422.00M
357.00M
Research and development expenses
118.00M
118.00M
114.00M
99.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
287.50M
287.50M
309.00M
299.00M
Operating expense
409.00M
409.00M
455.00M
566.00M
Total operating expenses
727.50M
727.50M
877.00M
923.00M
Operating income
10.00M
10.00M
-87.00M
-86.00M
Other non operating income
-500.00K
-500.00K
1.00M
1.00M
EBT including unusual items
1.00M
1.00M
-99.00M
-90.00M
EBT excluding unusual items
9.50M
9.50M
-86.00M
-85.00M
Income tax expense
11.50M
11.50M
12.00M
93.00M
Effective tax rate
1,150.00%
1,150.00%
-12.12%
-103.33%
Other operating expenses
3.50M
3.50M
32.00M
168.00M
Net income
-14.50M
-14.50M
-119.00M
-183.00M
Net profit margin
-1.97%
-1.97%
-15.06%
-21.86%
Earnings per share
-
-
0.08
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
49.00M
49.00M
-48.00M
-47.00M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer